loadpatents
Patent applications and USPTO patent grants for BALLANCE; David James.The latest application filed is for "elp fusion proteins comprising parathyroid hormone for controlled and sustained release".
Patent | Date |
---|---|
Elp Fusion Proteins Comprising Parathyroid Hormone For Controlled And Sustained Release App 20220289812 - BALLANCE; David James ;   et al. | 2022-09-15 |
Methods And Compositions For Treating Muscle Disease And Disorders App 20220288170 - GEORGOPOULOS; Lynne ;   et al. | 2022-09-15 |
Methods and compositions for treating muscle disease and disorders Grant 11,266,719 - Georgopoulos , et al. March 8, 2 | 2022-03-08 |
Methods And Compositions For Treating Cystic Fibrosis App 20220023390 - ARNOLD; Susan ;   et al. | 2022-01-27 |
Methods Of Reversing Ticagrelor Activity App 20210347915 - LEE; John ;   et al. | 2021-11-11 |
Methods and compositions for treating cystic fibrosis Grant 11,052,132 - Arnold , et al. July 6, 2 | 2021-07-06 |
Methods And Compositions For Treating Muscle Disease And Disorders App 20210069299 - GEORGOPOULOS; Lynne ;   et al. | 2021-03-11 |
Elp Fusion Proteins For Controlled And Sustained Release App 20200353091 - JOWETT; James ;   et al. | 2020-11-12 |
ELP fusion proteins for controlled and sustained release Grant 10,722,590 - Jowett , et al. | 2020-07-28 |
Methods and compositions for treating muscle disease and disorders Grant 10,688,156 - Georgopoulos , et al. | 2020-06-23 |
Elp Fusion Proteins For Controlled And Sustained Release App 20190218274 - JOWETT; James ;   et al. | 2019-07-18 |
Elp Fusion Proteins For Controlled And Sustained Release App 20190015523 - JOWETT; James ;   et al. | 2019-01-17 |
Methods And Compositions For Treating Muscle Disease And Disorders App 20180333467 - GEORGOPOULOS; Lynne ;   et al. | 2018-11-22 |
Albumin Fusion Proteins App 20180200346 - Ballance; David James ;   et al. | 2018-07-19 |
Methods And Compositions For Treating Cystic Fibrosis App 20170182130 - ARNOLD; Susan ;   et al. | 2017-06-29 |
Process for the purification of recombinant albumin Grant 9,555,344 - Van Urk , et al. January 31, 2 | 2017-01-31 |
Process for the purification of recombinant albumin Grant 9,029,102 - Van Urk , et al. May 12, 2 | 2015-05-12 |
Process For The Purification Of Recombinant Albumin App 20150056654 - Van Urk; Hendrik ;   et al. | 2015-02-26 |
Recombinant fusion proteins to growth hormone and serum albumin Grant 8,642,542 - Ballance February 4, 2 | 2014-02-04 |
Fusion protein of an exendin to modified transferrin Grant 8,158,579 - Ballance , et al. April 17, 2 | 2012-04-17 |
Process for the Purification of Recombinant Albumin App 20110301329 - Van Urk; Hendrik ;   et al. | 2011-12-08 |
Recombinant Fusion Proteins To Growth Hormone And Serum Albumin App 20110281800 - Ballance; David James | 2011-11-17 |
Exendin Fusion Proteins App 20110245178 - Ballance; David James ;   et al. | 2011-10-06 |
Process for the purification of recombinant albumin Grant 7,993,877 - Van Urk , et al. August 9, 2 | 2011-08-09 |
Fusion protein of exendin-4 to a transferrin (Tf) polypeptide Grant 7,867,972 - Ballance , et al. January 11, 2 | 2011-01-11 |
Recombinant Fusion Proteins To Growth Hormone And Serum Albumin App 20100261650 - Ballance; David James | 2010-10-14 |
Exendin Fusion Proteins App 20090239795 - BALLANCE; DAVID JAMES ;   et al. | 2009-09-24 |
Process for the Purification of Recombinant Albumin App 20090171070 - Van Urk; Hendrik ;   et al. | 2009-07-02 |
Recombinant fusion proteins to growth hormone and serum albumin Grant 7,550,432 - Ballance June 23, 2 | 2009-06-23 |
Recombinant fusion proteins to growth hormone and serum albumin App 20070299006 - Ballance; David James | 2007-12-27 |
Recombinant fusion proteins to growth hormone and serum albumin Grant 7,045,318 - Ballance May 16, 2 | 2006-05-16 |
Recombinant fusion proteins to growth hormone and serum albumin App 20030104578 - Ballance, David James | 2003-06-05 |
SEC | 0001755432 | Ballance David James |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.